Detection of Loss of Heterozygosity in cfDNA of Advanced EGFR- or KRAS-Mutated Non-Small-Cell Lung Cancer Patients

Lignende værker

• Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors
  af: Nardo, Giorgia, et al.
  Udgivet: (2021)
• Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer
  af: Zulato, Elisabetta, et al.
  Udgivet: (2020)
• Detection of LINE-1 hypomethylation in cfDNA of Esophageal Adenocarcinoma Patients
  af: Boldrin, Elisa, et al.
  Udgivet: (2020)
• Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort
  af: Fairclough, Stephen R., et al.
  Udgivet: (2019)
• Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome
  af: Pavan, Alberto, et al.
  Udgivet: (2021)